Latest Content

An Overview of Pancreatic Neuroendocrine Tumors (PNETs)

November 15th 2025, 7:00pm

By Alex Biese

Article

Breaking down the rare gastrointestinal cancer, from diagnosis to treatment.

Osteosarcoma Guide: Stages, Treatment, Side Effects and Patient Journey

November 15th 2025, 3:00pm

By Spencer Feldman

Article

This guide explains diagnosis, staging, treatment options, side effects and a patient’s metastatic experience with osteosarcoma.

TKIs Take Lead After Immunotherapy in Metastatic Kidney Cancer

November 14th 2025, 10:00pm

By Ryan Scott

Article

A real-world study found TKIs were the most common therapy for adults with metastatic renal cell carcinoma after prior immune checkpoint inhibitor use.

Higher BMI Linked to Better Survival in Localized Kidney Cancer

November 14th 2025, 9:00pm

By Spencer Feldman

Article

A study at IKCS finds higher BMI after kidney cancer diagnosis improves survival, while significant weight loss predicts poorer outcomes.

Kidney Cancer Disparities Persist Among American Indian and Alaskan Native Patients

November 14th 2025, 8:00pm

By Alex Biese

Article

American Indian and Alaskan Native individuals face some of the highest kidney cancer burdens in the United States.

Tribute to My Husband: A Partner Who Shows Up

November 14th 2025, 6:00pm

By Linda Cohen

Article

I want to appreciate and acknowledge the one person who has had a profoundly positive impact on me throughout my 16-year journey with chronic small lymphocytic lymphoma.

Understanding That Not All Lung Cancer Cases Are Linked to Smoking

November 14th 2025, 5:00pm

By Dr. Daniel J. Boffa

Video

In honor of Lung Cancer Awareness Month, CURE spoke with Dr. Daniel J. Boffa about how the understanding of lung cancer is evolving beyond smoking.

FDA Fast Tracks FOG-001 After Early Tumor Shrinkage in Desmoid Tumors

November 14th 2025, 4:00pm

By Spencer Feldman

Article

FOG-001 received fast track designation after early study results showed tumor shrinkage in all evaluable patients with desmoid tumors.

Breaking Down Advancements in Prostate Cancer Care

November 14th 2025, 2:00pm

By Dr. Joshua K. Sabari

Video

Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care.

Living With Purpose After a Metastatic Diagnosis

November 13th 2025, 10:00pm

By Michelle Viaene

Article

A woman shares how vision loss led to her cancer diagnosis and how lifestyle changes, support and community helped her regain control after her cancer had spread.

Shared Loss Leads to Lifelong Friendship in Rare Cancer Caregiving

November 13th 2025, 9:01pm

By Spencer Feldman

Article

Cindy and Katie share how caring for parents with cholangiocarcinoma led to friendship, support and advocacy through the Cholangiocarcinoma Foundation.

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

November 13th 2025, 7:25pm

By Ryan Scott

Article

The FDA approved Poherdy as the first interchangeable biosimilar to Perjeta for patients with HER2-positive breast cancer.

When One Blood Draw Could Tell More: A Look at the Cancerguard Test

November 13th 2025, 6:00pm

By Bonnie Annis

Article

As a breast cancer survivor, I try to stay up to date on new ways to detect cancer early. When I first heard about a simple blood test called Cancerguard, I sat up a little straighter.

FDA Grants Drug Designation to Tinostamustine for Malignant Glioma

November 13th 2025, 5:00pm

By Ryan Scott

Article

The FDA has granted orphan drug designation to tinostamustine, an investigational therapeutic, for the treatment of patients with malignant gliomas.

FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia

November 13th 2025, 4:00pm

By Alex Biese

Article

The FDA approved Komzifti in relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation.